Loading provider…
Loading provider…
Neurology Physician in Los Angeles, CA
NPI: 1114940731Primary Practice Location
UCLA Neurology Group Practice
300 Medical Plz, Los Angeles, CA
Primary Employer
UCLA Neurology Group Practice
uclahealth.org
HQ Phone
Get MD Jeff's Phone Numberphone_androidMobile
Get MD Jeff's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
1990 - 2025
CA State Medical License

American Board of Psychiatry and Neurology
Neurology
David Geffen School of Medicine at UCLA
medschool.ucla.edu
Medical School
Until 1988
UCLA David Geffen School of Medicine/UCLA Medical Center
Residency • Neurology
1989 - 1992
Los Angeles County-Harbor-UCLA Medical Center
Internship • Transitional Year
1988 - 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 137 | 286 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 41 | 52 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 23 | 23 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 14 | 14 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 14 | 30 |
Authors: Miriam Sklerov, Horacio Kaufmann, Brent Fogel, Un Kang, Roy Alcalay
Journal: Transl Neurodegener
Publication Date: 2023-03-20
Kindling induced changes in calmodulin kinase II immunoreactivity.
Authors: Bronstein, J M, Farber, D B, Micevych, P E, Lasher, R, Wasterlain, C G
Journal: Brain Res
Lead Sponsor: Alexion Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: SoC Therapy, DRUG: ALXN1840
Lead Sponsor: VA Office of Research and Development
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Lead Sponsor: University of California, Los Angeles
Collaborators: Michael J. Fox Foundation for Parkinson's Research
Intervention / Treatment: DRUG: placebo, DRUG: clartihromycin, amoxicillin, and omeprazole